Clinical Trials

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li.

Research suggests diabetes patients using SGLT-2 and DPP-4 inhibitors have a decreased risk of developing dementia.

How technology is enabling new access to clinical trials for those without the means to participate in traditional methods

If used correctly, AI and ML expand our knowledge of biology and vastly improve the speed of success in the clinic.

Discussing the finer points of AI as a catalyst for pharmaceutical innovation

How does prescreening improve clinical trials? Cara Brant, CEO of Clinical Trial Media, explains.

Older adults are underrepresented in clinical trials. This needs to change.

The burden on clinical trials designers and healthcare professionals can only be eased by fixing a broken process: trial feasibility.

The world is taking more interest in clinical trials. How are clinical trials adapting? Regeneron’s Bari Kowal keeps us updated.

Phesi CEO Gen Li discusses the impacts of the conflict between Russia and Ukraine on clinical trials